PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 2797556

  • 21. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 22. Management of the nephrotic syndrome.
    Linshaw MA, Gruskin AB.
    Clin Pediatr (Phila); 1974 Jan; 13(1):45-51. PubMed ID: 4588668
    [No Abstract] [Full Text] [Related]

  • 23. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J, Drummond KN.
    J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 25. Conventional therapy for idiopathic nephrotic syndrome in children.
    Brodehl J.
    Clin Nephrol; 1991 Aug; 35 Suppl 1():S8-15. PubMed ID: 1860269
    [Abstract] [Full Text] [Related]

  • 26. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA.
    Nephron; 1987 Aug; 46(1):73-7. PubMed ID: 3600915
    [Abstract] [Full Text] [Related]

  • 27. Should cyclosporine replace cytoxan or chlorambucil as the second-line drug for steroid-dependent nephrotic syndrome?
    Brouhard BH.
    Semin Nephrol; 1998 May; 18(3):367-9. PubMed ID: 9613881
    [No Abstract] [Full Text] [Related]

  • 28. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R, de Jong M, Monnens L.
    Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
    [Abstract] [Full Text] [Related]

  • 29. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N, Topaloglu R, Saatci O, Bakkaloglu A.
    Clin Pediatr (Phila); 1992 May 02; 31(5):283-8. PubMed ID: 1582094
    [Abstract] [Full Text] [Related]

  • 30. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
    Turk J Pediatr; 1999 May 02; 41(2):225-30. PubMed ID: 10770662
    [Abstract] [Full Text] [Related]

  • 31. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER, Sweny P, Chappel M, Varghese Z, Moorhead JF.
    Nephrol Dial Transplant; 1988 May 02; 3(6):728-32. PubMed ID: 3147413
    [Abstract] [Full Text] [Related]

  • 32. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K.
    J Nephrol; 2009 May 02; 22(5):610-5. PubMed ID: 19809993
    [Abstract] [Full Text] [Related]

  • 33. Treatment of the idiopathic nephrotic syndrome.
    Kleinknecht C, Broyer M, Jarde O, Guillot M.
    Paediatrician; 1981 May 02; 10(5-6):382-99. PubMed ID: 7036046
    [Abstract] [Full Text] [Related]

  • 34. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F.
    Proc Eur Dial Transplant Assoc; 1983 May 02; 19():717-23. PubMed ID: 6348763
    [Abstract] [Full Text] [Related]

  • 35. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K, Grisaru S, Stephens D, Arbus G.
    Clin Nephrol; 2001 Oct 02; 56(4):289-94. PubMed ID: 11680658
    [Abstract] [Full Text] [Related]

  • 36. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P, Bianchetti MG, Imoberdorf G, Lütschg J, Reymond D, Oetliker OH.
    Schweiz Med Wochenschr; 1994 May 14; 124(19):801-5. PubMed ID: 8209202
    [Abstract] [Full Text] [Related]

  • 37. [Clinical course and recurrences of the nephrotic syndrome due to minimal histologic lesions. Review of 73 cases (author's transl)].
    Vázquez Tadei G, Fernández J, Martin Malo A, Campdera FG, Sanz Guajardo D, Traver JA, Botella J.
    Med Clin (Barc); 1979 May 25; 72(10):401-4. PubMed ID: 470486
    [Abstract] [Full Text] [Related]

  • 38. Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial.
    Baluarte HJ, Hiner L, Gruskin AB.
    J Pediatr; 1978 Feb 25; 92(2):295-8. PubMed ID: 621612
    [Abstract] [Full Text] [Related]

  • 39. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec 25; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 40. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L, Böör A, Sasinka M.
    Cas Lek Cesk; 2008 Dec 25; 147(1):38-43. PubMed ID: 18323041
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.